Suppr超能文献

经镍(II)处理的雄性F344大鼠肾脏和肝脏中的氧化性DNA碱基损伤及其修复

Oxidative DNA base damage and its repair in kidneys and livers of nickel(II)-treated male F344 rats.

作者信息

Kasprzak K S, Jaruga P, Zastawny T H, North S L, Riggs C W, Olinski R, Dizdaroglu M

机构信息

Laboratory of Comparative Carcinogenesis, National Cancer Institute, FCRDC, Frederick, MD 21702, USA.

出版信息

Carcinogenesis. 1997 Feb;18(2):271-7. doi: 10.1093/carcin/18.2.271.

Abstract

DNA base damage was assayed using gas chromatography/ mass spectrometry with selected ion monitoring (GC/MS-SIM) in renal and hepatic chromatin of male F344 rats up to 14 days after a single i.p. injection of 90 micromol Ni(II) acetate/kg body wt. Ten different damaged bases were quantified. No damage was found in either organ 12 h after Ni(II) treatment. The damage became significant only from day 1, with magnitude and persistence depending on the organ and base. In livers, levels of five DNA base products were significantly elevated over those in control rats. They were: 8-oxoguanine (by 46% at day 1 postinjection); 2,6-diamino-4-hydroxy-5-formamidopyrimidine (by 107% at day 1); 5-(hydroxymethyl)uracil (by 94% at day 1); 5,6-dihydroxyuracil (by 128% at day 1); and 5-hydroxyhydantoin (by 39% in terms of the overall adjusted means for days 1-14 post-injection). The elevation was highest at day 1 post-injection followed by a decrease at later days, except for 5-hydroxyhydantoin. In kidneys, the levels of only three damaged bases, 8-oxoguanine, 5-hydroxyhydantoin and 5,6-dihydroxyuracil were increased significantly (by 31, 73 and 60%, respectively) and one base, 8-oxoadenine, was increased by 26%, just below significance, all in terms of overall adjusted means for days 1-14 post-injection. Hence, unlike those in the liver, the renal increases persisted for 14 days. The results reveal a tissue specific response to Ni(II)-mediated oxidative DNA base damage with apparently faster DNA repair in liver than in kidney, the main target of Ni(II) carcinogenicity.

摘要

在雄性F344大鼠腹腔注射90微摩尔/千克体重的醋酸镍(II)后长达14天的时间里,使用气相色谱/质谱联用选择离子监测(GC/MS-SIM)技术对其肾脏和肝脏染色质中的DNA碱基损伤进行了检测。对十种不同的受损碱基进行了定量分析。镍(II)处理12小时后,在任何一个器官中均未发现损伤。损伤仅从第1天开始变得显著,其程度和持续时间取决于器官和碱基。在肝脏中,五种DNA碱基产物的水平相对于对照大鼠显著升高。它们分别是:8-氧代鸟嘌呤(注射后第1天升高46%);2,6-二氨基-4-羟基-5-甲酰胺基嘧啶(第1天升高107%);5-(羟甲基)尿嘧啶(第1天升高94%);5,6-二羟基尿嘧啶(第1天升高128%);以及5-羟基乙内酰脲(注射后第1 - 14天的总体调整均值升高39%)。除5-羟基乙内酰脲外,注射后第1天升高幅度最大,随后在后续天数有所下降。在肾脏中,仅三种受损碱基,即8-氧代鸟嘌呤、5-羟基乙内酰脲和5,6-二羟基尿嘧啶的水平显著升高(分别升高31%、73%和60%),一种碱基8-氧代腺嘌呤升高了26%,略低于显著水平,所有这些均基于注射后第1 - 14天的总体调整均值。因此,与肝脏不同,肾脏中的升高持续了14天。结果揭示了对镍(II)介导的氧化性DNA碱基损伤的组织特异性反应,肝脏中的DNA修复明显比肾脏快,而肾脏是镍(II)致癌作用的主要靶器官。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验